Doxorubicin Terminated Phase 2 Trials for Refractory Nasopharyngeal Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00484601Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma